5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra 4/15/2024

4 Investigational Weight Loss Drugs That Could Change the Market 4/15/2024

Moderna Moves Cambridge Employees Into New Headquarters 4/4/2024

How to Manage Your Manager: Tips for Managing Up 4/4/2024

The Top 11 Companies Hiring in Biopharma Now 4/4/2024

WuXi AppTec Shared Client IP with Beijing, Say US Intelligence Officials: Reuters 3/29/2024

BMS’ Zeposia Fails to Meet Primary Endpoint in Phase III Crohn’s Trial 3/29/2024

Gilead Wins Label Expansion for Vemlidy to Treat Hepatitis B Virus in Kids 3/29/2024

FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months 3/29/2024

The IRA, Medicare and the High Costs of GLP-1 Drugs Like Wegovy 3/29/2024

What Lonza’s $1.2B Buy of Roche Biologics Plant Means for CDMO Market 3/29/2024

Avalo Snags Former Eli Lilly Asset and $185M in Major Pipeline Pivot 3/29/2024

Gamida Restructures Under Ownership of Highbridge Capital Management 3/29/2024

EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer 3/28/2024

Akebia’s CKD Anemia Drug Ends Tough Regulatory Path with FDA Approval 3/28/2024

Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of... 3/28/2024

Stoke Announces $125M Public Offering on Heels of Positive Data for Epilepsy Drug 3/28/2024

Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH 3/28/2024

Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy 3/28/2024

Boundless Bio Launches $100M IPO to Advance Cancer Therapy Candidates 3/28/2024